Old Web
English
Sign In
Acemap
>
authorDetail
>
Tomoyuki Suzuki
Tomoyuki Suzuki
Astellas Pharma
Molecular biology
Biology
Kinase
Immunology
Cancer
6
Papers
55
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2
2020
Bioorganic & Medicinal Chemistry
Ikumi Kuriwaki
Minoru Kameda
Hiroyuki Hisamichi
Shigetoshi Kikuchi
Kazuhiko Iikubo
Yuichiro Kawamoto
Hiroyuki Moritomo
Yutaka Kondoh
Yasushi Amano
Yukihiro Tateishi
Yuka Echizen
Yoshinori Iwai
Atsushi Noda
Hiroshi Tomiyama
Tomoyuki Suzuki
Masaaki Hirano
Show All
Source
Cite
Save
Citations (7)
ASP5878, a Novel Inhibitor of FGFR1, 2, 3, and 4, Inhibits the Growth of FGF19-Expressing Hepatocellular Carcinoma
2017
Molecular Cancer Therapeutics
Takashi Futami
Hidetsugu Okada
Rumi Kihara
Tatsuya Kawase
Ayako Nakayama
Tomoyuki Suzuki
Minoru Kameda
Nobuaki Shindoh
Tadashi Terasaka
Masaaki Hirano
Sadao Kuromitsu
Show All
Source
Cite
Save
Citations (24)
Abstract A172: Preclinical antitumor activity of ASP5878, a novel inhibitor of FGFR1, 2, 3 and 4, in FGF19-expressing hepatocellular carcinoma
2015
Molecular Cancer Therapeutics
Takashi Futami
Hidetsugu Okada
Rumi Kihara
Tatsuya Kawase
Ayako Nakayama
Tomoyuki Suzuki
Minoru Kameda
Nobuaki Shindoh
Tadashi Terasaka
Masaaki Hirano
Sadao Kuromitsu
Show All
Source
Cite
Save
Citations (1)
1